Zimmer Biomet
694 hedge funds and large institutions have $13.9B invested in Zimmer Biomet in 2013 Q4 according to their latest regulatory filings, with 85 funds opening new positions, 198 increasing their positions, 285 reducing their positions, and 36 closing their positions.
176% more call options, than puts
Call options by funds: $167M | Put options by funds: $60.7M
136% more first-time investments, than exits
New positions opened: 85 | Existing positions closed: 36
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
16% more capital invested
Capital invested by funds: $12B → $13.9B (+$1.87B)
7% more funds holding
Funds holding: 650 → 694 (+44)
1.02% less ownership
Funds ownership: 88.95% → 87.93% (-1%)
31% less repeat investments, than reductions
Existing positions increased: 198 | Existing positions reduced: 285
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sculptor Capital
New York
|
+$117M |
| 2 |
O
OrbiMed
New York
|
+$70.4M |
| 3 |
FAM
Fred Alger Management
New York
|
+$67.6M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$63.9M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$59.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
Longview Partners
St Peter Port,
Guernsey
|
-$161M |
| 2 |
HM
HealthCor Management
New York
|
-$77.9M |
| 3 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$45.4M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$36.3M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$35.2M |
ZBH Hedge Fund Activity: Q4 2013 in Review
694 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q4 2013, worth a combined $13.9B — up 16% from $12B a quarter earlier.
Buyers outnumbered sellers: 85 funds opened new ZBH positions and 36 closed out — a net gain of 49 holders — while 198 added to existing stakes and 285 trimmed.
The largest buyer was Sculptor Capital, opening a new position worth an estimated $117M. The largest seller was Longview Partners, exiting entirely with an estimated $161M sold.
- 694 institutional investors held Zimmer Biomet (ZBH) as of Q4 2013, up from 650 in Q3 2013.
- Funds reported $13.9B of Zimmer Biomet stock for Q4 2013, up 16% quarter-over-quarter.
- 85 funds opened new Zimmer Biomet positions in Q4 2013 and 36 closed out, a net change of +49 holders.
- The largest Zimmer Biomet buyer in Q4 2013 was Sculptor Capital, an estimated $117M added.
- The largest Zimmer Biomet seller in Q4 2013 was Longview Partners, an estimated $161M sold.
Based on aggregated 13F filings for Q4 2013.